Sun Genomics Announces Close of Series A Financing and Growth with New Talent and Scientific Advisor

SAN DIEGO, Sept. 16 (Korea Bizwire) – Sun Genomics, the direct-to-consumer custom probiotics and gut health company, announced today the close of $9.25 million in Series A funding. The round was led by Pangaea Ventures with new investments from Orion Fund, managed by K3 Ventures, and Emerging Technologies Partners. Additional investors include Danone Manifesto Ventures, SOSV, Human Longevity, and Nascita Ventures. “Among the [...]